A spontaneous variant of an antidigoxin hybridoma antibody with increased affinity arises from a heavy chain signal peptide mutation
- PMID: 1565100
- DOI: 10.1016/0161-5890(92)90010-u
A spontaneous variant of an antidigoxin hybridoma antibody with increased affinity arises from a heavy chain signal peptide mutation
Abstract
The A/J murine hybridoma cell line 40-150 secretes antidigoxin antibodies with high affinity for digoxin. A first-order spontaneous mutant (40-150 A2.4) produces antibodies containing a mutation at heavy chain position 94 resulting in reduced affinity for digoxin. A second-order mutant (40-150 A2.4 P.10) derived from 40-150 A2.4 produces two species of antibody: one identical to 40-150 A2.4 and the other with a two amino acid truncation at the heavy chain amino-terminus [Panka et al., Proc. natn. Acad. Sci. U.S.A. 85, 3080-3084 (1988)]. The truncated antibody has increased affinity for digoxin relative to the nontruncated variant. Direct nucleotide sequence analysis of polymerase chain reaction amplified heavy chain variable region cDNA derived from 40-150 A2.4 P.10 reveals a point mutation at the -2 position of the signal peptide, resulting in a glutamine to proline change. Southern blots of genomic DNA from all three cell lines gave identical patterns and were consistent with a single heavy chain mRNA derived from a single rearranged gene. The presence of proline at the heavy chain -2 position of antibody 40-150 A2.4 P.10 partially shifts the cleavage site of the signal peptidase to the +2 position, resulting in the production of both full-length and truncated antibody heavy chains. Signal peptide mutation resulting in a change in antibody affinity for antigen is a hitherto unidentified possible mechanism for antibody diversification.
Similar articles
-
Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.Protein Sci. 1994 May;3(5):737-49. doi: 10.1002/pro.5560030503. Protein Sci. 1994. PMID: 8061604 Free PMC article.
-
Heavy chain position 50 is a determinant of affinity and specificity for the anti-digoxin antibody 26-10.J Biol Chem. 1993 Oct 15;268(29):21739-47. J Biol Chem. 1993. PMID: 7691815
-
Characterization of the heavy and light chain immunoglobulin variable region genes used in a set of anti-digoxin antibodies.Mol Immunol. 1989 Apr;26(4):371-82. doi: 10.1016/0161-5890(89)90126-0. Mol Immunol. 1989. PMID: 2497340
-
Engineered antibodies as pharmacological tools.Immunol Rev. 1992 Dec;130:189-212. doi: 10.1111/j.1600-065x.1992.tb01526.x. Immunol Rev. 1992. PMID: 1286870 Review.
-
Somatic mutation alters affinity and specificity.Ann Inst Pasteur Immunol (1985). 1985 Mar-Apr;136C(2):267-71. doi: 10.1016/s0769-2625(85)80057-x. Ann Inst Pasteur Immunol (1985). 1985. PMID: 3890686 Review. No abstract available.
Cited by
-
Influence of the NH2-terminal amino acid of the T cell receptor alpha chain on major histocompatibility complex (MHC) class II + peptide recognition.J Exp Med. 1997 Jun 2;185(11):1919-27. doi: 10.1084/jem.185.11.1919. J Exp Med. 1997. PMID: 9166421 Free PMC article.
-
Rapid Analysis of Reduced Antibody Drug Conjugate by Online LC-MS/MS with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.Anal Chem. 2020 Nov 17;92(22):15096-15103. doi: 10.1021/acs.analchem.0c03152. Epub 2020 Oct 27. Anal Chem. 2020. PMID: 33108180 Free PMC article.
-
Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics.Antib Ther. 2022 Nov 11;6(1):13-29. doi: 10.1093/abt/tbac029. eCollection 2023 Jan. Antib Ther. 2022. PMID: 36683767 Free PMC article. Review.
-
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants.Antibodies (Basel). 2022 Nov 20;11(4):73. doi: 10.3390/antib11040073. Antibodies (Basel). 2022. PMID: 36412839 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials